NCT03613129View on ClinicalTrials.gov

Clinical Trial to Investigate CT38 in the Treatment of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 23, 2018

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Myalgic EncephalomyelitisChronic Fatigue Syndrome
Interventions
DRUG

CT38

Infusion

Trial Locations (1)

84102

Bateman Horne Center, Salt Lake City

All Listed Sponsors
lead

LUCINDA BATEMAN, MD

OTHER

NCT03613129 - Clinical Trial to Investigate CT38 in the Treatment of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome | Biotech Hunter | Biotech Hunter